Cytotoxic Activity of Peripheral Blood Lymphocytes Grown with Interleukin 2 against Autologous Cultured Tumor Cells in Patients with Renal Cell Carcinoma: Preliminary Report-Reference-Cited by-同舟云学术

Cytotoxic Activity of Peripheral Blood Lymphocytes Grown with Interleukin 2 against Autologous Cultured Tumor Cells in Patients with Renal Cell Carcinoma: Preliminary Report

Published:1985-07 Issue:1 Volume:134 Page:24-28
ISSN:0022-5347
Container-title:Journal of Urology
language:en
Short-container-title:Journal of Urology

Author:

Nakano Etsuji¹,Tada Yasuharu¹,Ichikawa Yasuji¹,Fujioka Hideki¹,Ishibasi Michio¹,Matsuda Minoru¹,Takaha Minato¹,Sonoda Takao¹

Affiliation:

1. From the Department of Urology, Osaka University School of Medicine, Osaka, Japan

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Urology

Reference27 articles.

1. Current therapy for renal cell carcinoma;McDonald;J. Urol.,1982

2. Treatment of advanced renal cell carcinoma—traditional methods and innovative approaches;deKernion;J. Urol.,1983

3. Hormone receptor in renal cell carcinoma and correlation with clinical response to endocrine therapy;Nakano;J. Urol.,1984

4. Spontaneous regression of pulmonary metastases after nephrectomy for renal cell carcinoma;Nakano;Eur. Urol.,1984

5. Late recurrence of renal cell carcinoma after nephrectomy;Nakano;Eur. Urol.,1984

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Enhancement of Interleukin-2-Induced Lymphokine-Activated Killer Activity by Interleukin 7 against Autologous Human Renal Cell Carcinoma;Oncology;1998

2. Cytotoxic In vitro function in patients with metastatic renal cell carcinoma before and after alpha-2b-interferon therapy effects of activation with recombinant interleukin-2;Cancer;1992-05-15

3. Induction of cytotoxicity of the renal hilar lymph nodes by pedal subcutaneous administration of interleukin-2 in patients with renal cancer;Cancer;1991-03-01

4. In vitro activation of lymphocytes by interleukin 2 in patients with renal cell carcinoma;Urology;1989-02

5. Immunotherapy;Combination Therapy in Urological Malignancy;1989